Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Sorry? So yeah, what's your point?
View:
Post by Red~One on Jan 19, 2022 10:52am

Sorry? So yeah, what's your point?

" January 4 we were 'negotiating' for rights however, Jan.17 we announced that the negotiations are over and we "will enter into a new license agreement" Your Quote


So yeah, what's your point?

Next we'll have an update on the same thing saying "we negotiated, see previous Update, then we announced we will enter into a new license, see previous update, then another update saying we have finally entered into the agreement subject to TSX -V approval, then another update saying we have approval bt need to raise cash, then another update saying cash is found but the Claritas team need to make room for 1.2 million more shares....then another update.................

4 or 5 updates about the same thing is not a very strong fundamental until the announced intent is actually done. Am I missing something here , you don't seem to know how these Penny stocks work. You can't say the same thing 5 different times and expect a good response from intelligent shareholders.
Comment by PTBailey on Jan 19, 2022 11:30am
You do know there is difference between negotiating for an agreement and actually signing or having it approved and finalized.  So yes it seems you are missing something. "You can't say the same thing 5 different times and expect a good response from intelligent shareholders." Actually I "assumed" I was speaking to one, don't dissappoint me.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities